These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 38926967)
1. [Clinical Significance of Serum ADA Combined with GLB, CREA, β Qian H; Yuan HL; Zhang T; Yang YW; Feng JF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):780-788. PubMed ID: 38926967 [TBL] [Abstract][Full Text] [Related]
2. [Correlation analysis of polyclonal plasma cell proportion in the bone marrow with clinical characteristics of patients with newly diagnosed multiple myeloma]. Long XL; Wang XR; An N; Liu SY; Li Z; Li CH; Mu W; Wang D; Li CR Zhonghua Xue Ye Xue Za Zhi; 2024 May; 45(5):475-480. PubMed ID: 38964922 [No Abstract] [Full Text] [Related]
3. [Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma]. Xu SQ; Zhao P; Wang ZH; Deng H; Zhang L; Wei J; Zou XL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Aug; 29(4):1216-1223. PubMed ID: 34362505 [TBL] [Abstract][Full Text] [Related]
4. [The roles of serum free light chain ratio in the diagnosis and prognosis of newly diagnosed multiple myeloma]. Wang PF; Xu Y; Yan S; Yao Y; Zheng HF; Ma L; Jin S; Xu Y; Gong FR; Zhou JZ; Chang HR; Fu CC Zhonghua Xue Ye Xue Za Zhi; 2016 May; 37(5):377-82. PubMed ID: 27210871 [TBL] [Abstract][Full Text] [Related]
5. Significance of Common Blood Test Indexes in the Diagnosis and Prognosis of Multiple Myeloma. Chen S; Zhou M; Yang J; Cheng YR; Li Y; Lu K; Hu W; Hua N; Wang Y; Tong X Clin Lab; 2022 Apr; 68(4):. PubMed ID: 35443602 [TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of multiple myeloma in Hunan Province. Liu F; Cheng Q; Song K; Yu H; Li J; Zhang H; Hu G; Zhou M; Wang J; Ding Z; Luo Z; Peng T; Ding L; Zhao L; Liu J; He Y; Peng H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):497-504. PubMed ID: 35545345 [TBL] [Abstract][Full Text] [Related]
7. Characterization of peripheral blood inflammatory indicators and OCT imaging biological markers in diabetic retinopathy with or without nephropathy. Xiaodong L; Xuejun X; Xiaojuan S; Yu H; Mingchao X Front Endocrinol (Lausanne); 2023; 14():1160615. PubMed ID: 37465123 [TBL] [Abstract][Full Text] [Related]
8. A Retrospective Analysis: A Novel Index Predicts Survival and Risk-Stratification for Bone Destruction in 419 Newly Diagnosed Multiple Myelomas. Jin Y; Shang Y; Liu H; Ding L; Tong X; Tu H; Yuan G; Zhou F Onco Targets Ther; 2019; 12():10587-10596. PubMed ID: 31819538 [TBL] [Abstract][Full Text] [Related]
9. Analysis of coagulation alteration and its correlation with β2-microglobulin in 371 patients with newly diagnosed multiple myeloma. Hu M; Ma Y; Jia K; Liu S; Jing H; Li R Hematology; 2024 Dec; 29(1):2377849. PubMed ID: 38994877 [TBL] [Abstract][Full Text] [Related]
10. Eastern Cooperative Oncology Group, Lu X; Liu W; Zhang L; Chen X; Yang L; Yao Q; Zhao J; He S; Wei J; Tian W Front Microbiol; 2023; 14():1114972. PubMed ID: 36778870 [TBL] [Abstract][Full Text] [Related]
11. [Effect of Serum Free Light Chain on Renal Function and Prognosis in Patients with Newly Diagnosed Multiple Myeloma]. Chen XD; Luo XF; Zu YP; Ye H; Li LL; Chen QL; Xie WZ; Yang T; Hu JD; Wei LX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1862-1868. PubMed ID: 31839051 [TBL] [Abstract][Full Text] [Related]
12. [Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma]. Xiao ZF; Zou SS; Yi CF; Zhao Y; Wu LS; Feng YH Zhonghua Xue Ye Xue Za Zhi; 2024 Jul; 45(7):672-677. PubMed ID: 39231772 [No Abstract] [Full Text] [Related]
13. [Expression and Clinical Significance of Lu L; Guo D; Hong LM; Jiang YW; Fan HM; Huang CQ; Lu JF; Chen J; Xu HH; Huang HM Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):789-793. PubMed ID: 38926968 [TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia caused by humoral effects and bone damage indicate poor outcomes in newly diagnosed multiple myeloma patients. Bao L; Wang Y; Lu M; Chu B; Shi L; Gao S; Fang L; Xiang Q Cancer Med; 2020 Dec; 9(23):8962-8969. PubMed ID: 33145966 [TBL] [Abstract][Full Text] [Related]
15. [The Relationship Between Serum CysC, β2-MG and the Efficacy of Demethylation Therapy in Patients with Acute Myeloid leukemia]. Zhang CH; Su RJ; Huang BT; Wang ZL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1005-1010. PubMed ID: 39192390 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Red Blood Cell Distribution Width and Multiple Myeloma in a Guangxi Population: a Retrospective Study. Huang C; Wei H; Lan F; Lu Y; Li S; Qin X Clin Lab; 2019 Mar; 65(3):. PubMed ID: 30868861 [TBL] [Abstract][Full Text] [Related]
17. [Values of Detecting the Levels of β2-MG, TNF-α, CRP, IL-6 in the Patients with Multiple Myeloma]. Duan LJ; Li C; Yang RY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1362-5. PubMed ID: 26524038 [TBL] [Abstract][Full Text] [Related]
18. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C. Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154 [TBL] [Abstract][Full Text] [Related]
19. [Analysis of the international staging system of multiple myeloma and its comparison with the DS and IFM staging system in 122 Chinese patients]. Deng SH; Xu Y; Mai YJ; Wang YF; Zhao YZ; Zou DH; Qiu LG Zhonghua Xue Ye Xue Za Zhi; 2008 Apr; 29(4):217-21. PubMed ID: 18843972 [TBL] [Abstract][Full Text] [Related]
20. Optimal cut-off values and diagnostic significance of clinical laboratory indicators in newly diagnosed multiple myeloma. Li M; Wu H; Shou C; Peng Y; Song X; Ying W; Chen Y; Tong X Discov Oncol; 2024 Sep; 15(1):477. PubMed ID: 39331239 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]